HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of tubular creatinine secretion as the only sign of tubular proximal cell dysfunction in light chain proximal tubulopathy: A case report.

Abstract
Light chain proximal tubulopathy (LCPT) is a rare disease, characterized by cytoplasmic inclusions of light chain (usually kappa) immunoglobulins. Clinical presentation is usually a Fanconi syndrome. The proximal tubular dysfunction can be incomplete, and exceptional cases of LCPT without any tubular dysfunction have even been described. Here, we report a case of LCPT in which the only sign of proximal tubulopathy is the absence of secretion of creatinine, as assessed by the simultaneous measurement of renal clearance of creatinine and CrEDTA. The loss of tubular creatinine secretion as a sign of tubular proximal cell dysfunction ought to be identified in patients with light chain proximal tubulopathy as it leads to a clinically relevant underestimation of GFR by the creatinine-derived equations. The prevalence and prognostic significance of this particular proximal tubular damage in LCPT remain to be determined.
AuthorsThomas Stehlé, Marguerite Vignon, Martin Flamant, Marie-Lucile Figueres, Marion Rabant, Anita Rodenas, Laure-Hélène Noël, Bertrand Arnulf, Emmanuelle Vidal-Petiot
JournalMedicine (Medicine (Baltimore)) Vol. 95 Issue 26 Pg. e3815 (Jun 2016) ISSN: 1536-5964 [Electronic] United States
PMID27367983 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin Light Chains
  • Creatinine
Topics
  • Adult
  • Creatinine (metabolism)
  • Humans
  • Immunoglobulin Light Chains
  • Kidney Diseases (metabolism, pathology)
  • Kidney Tubules, Proximal (cytology, metabolism)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: